Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 4Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma 1Leukemia, Myeloid, Accelerated Phase 1Hodgkin Disease 1Blast Crisis 1

Interventions

Peripheral Blood Stem Cell Transplantation 13Tacrolimus 7Busulfan 7fludarabine phosphate 6Mycophenolic Acid 6Methotrexate 6Imatinib Mesylate 6Cyclosporine 6Filgrastim 5Cyclophosphamide 5Whole-Body Irradiation 3Decitabine 3Cytarabine 3ponatinib 2nilotinib 2bosutinib 2aldesleukin 2Thiotepa 2Stem Cell Transplantation 2Radiotherapy 2Melphalan 2Flow Cytometry 2Etoposide 2Cord Blood Stem Cell Transplantation 2Blood Specimen Collection 2Arsenic Trioxide 2Antilymphocyte Serum 2venetoclax 1vatalanib 1ruxolitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Blast Crisis × Methylprednisolone Acetate × Clear all
NCT00002831 2018-10-26

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia

M.D. Anderson Cancer Center

Phase 1/2 Completed
24 enrolled
Other hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡